2016 Financial Press Releases

Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
09/27/16Prospective, Multi-Institutional Study Shows Five Treatments with the CyberKnife® System Provide Excellent Disease Control for Prostate Cancer Patients
ASTRO Selects the Data for Center Stage at Largest Annual Meeting of Radiation Oncologists SUNNYVALE, Calif., Sept. 27, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, 21 center study showed 97 percent of low- and intermediate-risk prostate cancer patients had excellent cancer control five years after receiving stereotactic body radiation therapy (SBRT) administered with the CyberKnife® System. The treatment was extremely well-tolerated... 
Printer Friendly Version
09/22/16Accuray to Unveil New Technology at the ASTRO 2016 Annual Meeting
Innovations in Hardware and Software Solutions and New Clinical Data Reinforce the Benefits of Accuray Systems in Treating a Wide Range of Cancer Cases SUNNYVALE, Calif., Sept. 22, 2016 /PRNewswire/ -- New data on the Accuray (NASDAQ: ARAY) CyberKnife® and TomoTherapy® Systems will be shared by leading radiation oncology practitioners, and the Company's new, innovative radiation therapy treatment delivery system, the Radixact™ System, and treatment planning software, will be unveiled at the... 
Printer Friendly Version
09/06/16Accuray to Participate in the Morgan Stanley Global Healthcare Conference 2016
SUNNYVALE, Calif., Sept. 6, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 14, 2016 at 8:45 a.m. ET.   A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will be... 
Printer Friendly Version
08/17/16Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results
Achieves Record Backlog of $405.9 Million as Q4 Gross Orders Increase 12 Percent Announces Fiscal 2017 Guidance SUNNYVALE, Calif., Aug. 17, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2016. Q4 Fiscal 2016 Highlights Gross orders increased 12 percent over the prior year period to $95.4 million CyberKnife® System gross orders highest in the Company's history TomoTherapy® Syste... 
Printer Friendly Version
08/09/16Accuray CE Marks its New Radixact™ System
Next Generation Image-Guided Radiation Therapy Platform and Integrated Software Solutions are Now Available for Use by Clinicians in the European Union SUNNYVALE, Calif., Aug. 9, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that it has CE marked its Radixact™ Treatment Delivery System, Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. The next generation hardware and software solutions, together, make up the new Radixact platform, whi... 
Printer Friendly Version
08/04/16New Data Show InCise™ Multileaf Collimator for the CyberKnife® M6™ System may Expand Patient Population Eligible for Precise Radiation Treatments
Clinical Research on the CyberKnife® System, Including the Multileaf Collimator, Presented at Leading Scientific Meeting for Medical PhysicistsSUNNYVALE, Calif., August 4, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that more than 45 studies on the use of the CyberKnife® System were presented during poster and oral sessions at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 – August 4, 2016. The ... 
Printer Friendly Version
08/04/16New Data Demonstrating TomoTherapy® System Adaptive Capabilities and Workhorse Reliability Presented at Leading Scientific Meeting for Medical Physicists
Clinical Research Also Showcases Innovative Approaches to Expanding TomoTherapy Platform Functionality SUNNYVALE, Calif., Aug. 4, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new studies demonstrating the TomoTherapy® System's leading-edge adaptive therapy capabilities and value as a mainstream radiation therapy device were presented at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 – Augu... 
Printer Friendly Version
08/02/16Accuray Retires Remaining 3.75% Convertible Debt
SUNNYVALE, Calif., Aug. 2, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the Company has settled the remaining principal amount and accrued interest thereon of the 3.75% Convertible Senior Notes (the "2016 Notes"). The 2016 Notes were settled on August 1, 2016 for cash of $37.3 million, which included $36.6 million in principal and $0.7 million in accrued interest. On August 1, 2011, the Company issued the 2016 Notes with a $100.0 million aggregate principal valu... 
Printer Friendly Version
07/21/16TomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients
SUNNYVALE, Calif., July 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated partial breast irradiation (APBI) in patients treated with the TomoTherapy® System. The study, published in the June issue of the peer-reviewed AntiCancer Research, International Journal of Cancer Research and Treatment, reported no recurrence of cancer in the treated breast at median follow-up of 34 months. ... 
Printer Friendly Version
07/14/16Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report
User Satisfaction Ratings Exceed Industry Average for 11 Consecutive Quarters SUNNYVALE, Calif., July 14, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the standard for overall user satisfaction.  The Accuray systems received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2016 MD Buyline Market Intelligence Briefing™. Th... 
Printer Friendly Version
07/07/16Accuray To Report Fiscal 2016 Fourth Quarter And Full Year Results On August 17, 2016
SUNNYVALE, Calif., July 7, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal fourth quarter and full year ended June 30, 2016 on Wednesday, August 17, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International).  In addition, a dial up replay of the conference call will be available ap... 
Printer Friendly Version
06/27/16Accuray Receives 510(k) FDA Clearance for the Radixact™ Image-Guided Radiation Therapy Platform and Integrated Software
Next Generation "Smart" System Enables Clinicians to Provide Highly Precise Treatment, Efficiently, for More Patients, Every Day SUNNYVALE, Calif., June 27, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radixact™ Treatment Delivery Platform. Accuray also received 510(k) clearance for its new treatment planning and data management systems, Accuray Precision™ Treatment Planning... 
Printer Friendly Version
06/21/16FUCAM Treats 1,000 Breast Cancer Patients with the TomoTherapy® System
System Dedicated Solely to Breast Cancer Care Provides Excellent Clinical Outcomes SUNNYVALE, Calif., June 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Fundación de Cancer de Mama in México City (FUCAM) has treated 1,000 breast cancer patients with the TomoTherapy® System. The milestone was achieved less than 18 months after the center installed the technology, underscoring its value as a mainstream treatment option to maximize tumor control with low... 
Printer Friendly Version
06/16/16United Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy® Systems
Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments SUNNYVALE, Calif., June 16, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) has a signed deal with NHS Supply Chain for seven TomoTherapy® Systems in a new partnership designed to provide clinicians and their patients with additional access to advanced radiation therapy. This deal was entered into backlog during Accuray's fourth fiscal quarter. Thi... 
Printer Friendly Version
05/25/16Accuray to Participate in the 2016 Jefferies Healthcare Conference
SUNNYVALE, Calif., May 25, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference in New York, NY on Friday, June 10, 2016 at 8:00 a.m. ET.   A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately... 
Printer Friendly Version
05/19/16Accuray to Host Analyst and Investor Day on May 20, 2016
SUNNYVALE, Calif., May 19, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst and Investor Day on Friday, May 20, 2016 at the Lotte Palace Hotel in New York City. Presentations will begin at 8:30 a.m. ET and a webcast with accompanying slides will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors.  A replay of the webcast will also be available on the Company's website followin... 
Printer Friendly Version
05/01/16Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife® System
Collaboration Designed to Expand Clinical Versatility of the CyberKnife® System with Addition of medPhoton Novel Imaging Solution SUNNYVALE, Calif., May 1, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with medPhoton GmbH to collaborate on integration of its ImagingRing® system, a new technology for volumetric image guidance, with the CyberKnife® System. The ImagingRing provides a range of advanced imaging capabilities incl... 
Printer Friendly Version
04/26/16Accuray Submits 510(k) Premarket Notification to FDA for Its Radixact™ Treatment Delivery System
SUNNYVALE, Calif., April 26, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the submission of its 510(k) premarket notification with the Food and Drug Administration (FDA) for the company's Radixact™ Treatment Delivery System. Accuray also submitted 510(k) premarket notification for its treatment planning and data management systems, Precision™ Treatment Planning System and iDMS™ Data Management System. The treatment delivery system, Precision Treatment Planning S... 
Printer Friendly Version
04/26/16Accuray Generates $105.3 Million in Third Quarter Revenues
Achieves 8% year-over-year revenue growth; Generates $5.4 million of operating income SUNNYVALE, Calif., April 26, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2016. Fiscal Third Quarter Highlights Gross orders were $56.4 million; 9% year-over-year growth; Net orders were $57.6 million; 60% year-over-year growth Ending product backlog was $370.5 million; 7% year-over-year ... 
Printer Friendly Version
04/22/16Accuray Hosts Regional AERO Users' Meeting
Leading Oncology Specialists Discuss Best Practices and Innovations in Cancer Treatment SUNNYVALE, Calif., April 22, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the Accuray Exchange in Radiation Oncology (AERO™) Users' Meeting was held April 10 – 11, 2016 at the Palace Hotel in San Francisco, California. The two day summit, coordinated in partnership with teams from several University of California campuses, brought together radiation oncologists, physicist... 
Printer Friendly Version
04/06/16Accuray To Report Results For Third Quarter Fiscal 2016 On April 26, 2016
SUNNYVALE, Calif., April 6, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2016 on April 26, 2016 after the market close.  Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after the ... 
Printer Friendly Version
03/31/16MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients with the CyberKnife® System
Patients Benefit from Fewer Treatment Sessions and Minimal Side Effects SUNNYVALE, Calif., March 31, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that MedStar Georgetown University Hospital in Washington, D.C. treated its 1,000th prostate cancer patient with the leading-edge CyberKnife® System. The System was designed to deliver stereotactic body radiation therapy (SBRT), a treatment process necessitating an extremely high degree of precision. SBRT is a much shorte... 
Printer Friendly Version
02/24/16Accuray to Participate in the 36th Annual Cowen and Company Health Care Conference
SUNNYVALE, Calif., Feb. 24, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the 36th Annual Cowen and Company Health Care Conference in Boston, MA on Monday, March 7, 2016 at 3:20pm ET.   A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will be... 
Printer Friendly Version
01/28/16Accuray Generates $108.9 Million in Second Quarter Revenues
Record Revenues Achieved as Commercial Execution Continues; Management Reaffirms Fiscal 2016 Guidance SUNNYVALE, Calif., Jan. 28, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2015. Fiscal Second Quarter Highlights Gross orders were $67.1 million; single and dual vault sites comprised more than 50 percent of total TomoTherapy® System orders; replacement orders to existing ac... 
Printer Friendly Version
01/19/16Accuray Announces Repurchases of Convertible Debt
SUNNYVALE, Calif., Jan. 19, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that between January 11 and January 15, 2016, the company, in privately-negotiated transactions, had repurchased approximately $63.4 million in aggregate principal amount of its 3.75% Convertible Senior Notes due August 2016 (the "2016 Notes") for $66.6 million in cash. The company anticipates that the closings of these repurchases will be completed by January 20, 2016. Following the closing... 
Printer Friendly Version
01/14/16Accuray Announces First Radiation Therapy Systems Installed in Qatar, Latvia and Bulgaria
Premier Qatar, Latvian Cancer Centers to Offer Patients Treatment with the CyberKnife® System; Leading Bulgarian Hospital to Provide Treatment with the TomoTherapy® System SUNNYVALE, Calif., Jan. 14, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the first centers in Qatar, Latvia, and Bulgaria are now equipped with its radiation therapy technology, demonstrating continued momentum in adoption of its devices in Europe, India, the Middle East and Africa (EIMEA). ... 
Printer Friendly Version
01/12/16Accuray Closes $70 Million Straight Debt Financing
SUNNYVALE, Calif., Jan. 12, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has closed a $70 million straight debt financing agreement with Cerberus Business Finance, LLC, an affiliate of Cerberus Capital Management, L.P. The net proceeds of the loan are required to be used, in addition to $30 million of cash funded by Accuray, to retire $100 million of convertible notes at the earlier of August 2016 or when otherwise redeemed. This financing consists of a $70 mi... 
Printer Friendly Version
01/11/16Accuray Announces Preliminary Second Quarter Financial Results
Revenue Expected to be Approximately $107.5 Million; Gross Orders Expected to be Approximately $67 Million Management Reiterates Guidance for FY2016 SUNNYVALE, Calif., Jan. 11, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary product orders and revenues for the second quarter of fiscal 2016, which ended on December 31, 2015. As a result of the expected second quarter results and current business trends, management today reaffirmed guidance for FY 2016. ... 
Printer Friendly Version
01/07/16Accuray To Report Results For Second Quarter Fiscal 2016 On January 28, 2016
SUNNYVALE, Calif., Jan. 7, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2015 on January 28, 2016 after the market close.  Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after t... 
Printer Friendly Version
01/04/16Accuray to Participate in the 34th Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Jan. 4, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine, president and chief executive officer, is scheduled to present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 12, 2016 at 4:30pm PDT / 7:30pm ET.   A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of th... 
Printer Friendly Version